Showing results (251-260 of 359) with videos related to
Sort By:
Pageof 36
Psychotherapy (Chicago, Ill.)|December 7, 2011
Alliance-focused therapy for anorexia nervosa: integrative relational and behavioral change treatments in a single-case experimental designDana A Satir, David M Goodman, Rebecca M Shingleton, et al.British Journal of Cancer|November 26, 2009
Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitroM Prencipe, P Fitzpatrick, S Gorman, et al.Cancer Chemotherapy and Pharmacology|March 16, 2007
Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetateLee Jia, Lori C Coward, Corenna D Kerstner-Wood, et al.Communications Biology|October 23, 2023
A novel mouse model of mitochondrial disease exhibits juvenile-onset severe neurological impairment due to parvalbumin cell mitochondrial dysfunctionElizaveta A Olkhova, Carla Bradshaw, Alasdair Blain, et al.Journal of Medicinal Chemistry|May 11, 2022
Nontoxic Tumor-Targeting Optical Agents for Intraoperative Breast Tumor ImagingSamer A Naffouje, Masahide Goto, Lori U Coward, et al.Gut|April 1, 1975
Ileal function in patients with untreated adult coeliac diseaseD B Silk, P J Kumar, J P Webb, et al.Neuromuscular Disorders : NMD|April 20, 2012
Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A>G mutation and correlates with mutation loadKieren G Hollingsworth, Grainne S Gorman, Michael I Trenell, et al.Journal of Neurology|October 24, 2013
Discrete gait characteristics are associated with m.3243A>G and m.8344A>G variants of mitochondrial disease and its pathological consequencesBrook Galna, Jane Newman, Djordje G Jakovljevic, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|October 8, 2004
Pharmacokinetics of perfluorooctanoate in cynomolgus monkeysJ L Butenhoff, G L Kennedy, P M Hinderliter, et al.Journal of Neuromuscular Diseases|August 28, 2023
Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1Valeria Di Leo, Conor Lawless, Marie-Pier Roussel, et al.Pageof 36